News About: Pharm. Industry
Pharmicell & Green Cross have largest ratios of R&D employees
1.5 of 10 employees working in pharmaceutical companies were known to engage in the R&D field.
According to the aggregation result of 34 companies who open public the number of researchers and developers in their 20...
Will return of President Jay-Hyun Lee accelerate IPO process?As President Jay-Hyun Lee of CJ Group went free by the President’s special pardons on the Liberation Day, CJ HealthCare is expected to accelerate a procedure to go public.
CJ...
|
Chance to tie up multiple pharmaceuticals over rebate concerns the industry
Since the Busan District Prosecutor’s Office concentrates on investigating pharmaceutical companies’ rebates related to Kosin University Gospel Hospital, the pharmaceutical industry is keeping a close watch on the inv...
“MOHW will make decision after court’s judgment on Novartis’ rebate”The Ministry of Health and Welfare(MOHW) announced it is considering to take measures on Novartis for the rebate crisis after the court’s judgment. Since it will take a number o...
|
Celltrion cruising to launch Truxima with nullifying relevant patents in KoreaCelltrion announced the Intellectual Property Tribunal ruled patent nullification related to an original ‘Rituxan’ patent owned by Biogen on the 23rd of August.
In order to com...
|
KPMA reveals a pharmaceutical company suspicious of rebate activities
The Korea Pharmaceutical Manufacturers Association(KPMA) will change its name. Also, it revealed pharmaceutical companies suspicious of illegal rebates.
The KPMA held the 4th board of directors on the 23rd, tabled an...
Spun-off GSK Consumer Healthcare reducing staffs‘GSK Consumer Healthcare’ was confirmed to work on staff reduction.
The company is an independent company that was spun off from the GSK’s OTC & Consumer Goods Department.
A...
|
Sanofi’s fueled labor-management conflicts, focusing on level of disciplinary dismissalRecently, a series of large rebates crises have stressed ethical management in the pharmaceutical industry.
Among companies in the industry, Sanofi is known to have conflicts...
|
No extended investigation on Novartis’ rebate crisis
Starting with the search and seizer on January, the investigation related to Novartis’ rebate bribery seems to come to an end with an announcement of the investigation result on the 10th.
After the announcement, the ...
Why Korea Pharmaceutical Manufacturers Association include Bio-Pharm in its name?
The Korea Pharmaceutical Manufacturers Association, which was originated from the Joseon Pharmaceutical Association after participated by 65 pharmaceutical companies on October 1945, is planning to change its name to ...